EMC's new VoIP tools are Aussie through and through

Stuart Corner
Wednesday, 22 August 2007 06:01

Opinion and Analysis

EMC has just announced "the market's most comprehensive solutions for managing VoIP and IP telephony environments," without mentioning that they were developed by an Australian company.

EMC's press release says that with EMC Smarts VoIP Performance Manager and EMC Smarts VoIP Performance Reporter, "customers can maximise the availability and performance of business-critical VoIP services through comprehensive monitoring, alerting, diagnosis and reporting on all aspects of a system that may impact IP telephony services...the software effectively analyses data from multiple sources to pinpoint the root cause of IT infrastructure problems automatically and in real-time – enabling companies to more effectively maximise the availability and performance of critical IT resources and the business services (such as VoIP) they support."

EMC says that it "now boasts the most comprehensive VoIP solution for monitoring the end-to-end performance and availability of both the VoIP telephony and supporting network infrastructures. According to Chris Gahagan, EMC's senior vice president, resource management software, "Smarts VoIP Performance Manager and Smarts VoIP Performance Reporter are truly breakthrough solutions for managing today's complex VoIP telephony infrastructures...Leveraging Smarts software, customers not only optimise call quality, improve reliability and reduce mean-time-to-repair – but they can also simplify management of geographically dispersed and hybrid environments. The end result gives customers what they expect from today's VoIP deployments – maximised service levels, lower operating costs and dramatic improvements in employee productivity."

It all sounds very splendid, but if EMC had wanted to really brag about the capabilities of these products it could have fessed up to their origins and it would then have been able to boast about their large and impressive base of existing customers. For they are better known by the name Prognosis and were developed and have been sold for a good number of years by Sydney based Integrated Research (ASX: IRI).